Role of cyclopegics in progressive myopia

Area of Science:

• Ophthalmology
• Pediatric Medicine
• Pharmacology

Background:

• Myopia, or nearsightedness, is a growing public health concern in children.
• Current treatments for myopia progression primarily involve corrective lenses.
• The potential of pharmacological interventions to manage myopia requires further investigation.

Purpose of the Study:

• To evaluate the efficacy and safety of low-dose atropine sulfate in slowing the progression of myopia in children.
• To assess long-term effects on ocular health parameters.

Main Methods:

• A cohort of 86 children (172 eyes) received daily 1% atropine sulfate eye drops for 2-8 years.
• Ocular health was monitored for changes in intraocular pressure, pupillary response, accommodation, and fundus appearance.
• A control group receiving only corrective lenses was used for comparison.

Main Results:

• Atropine sulfate treatment showed significant efficacy in reducing myopia progression compared to the control group.
• No adverse effects were observed in intraocular pressure, pupillary response, accommodation, or ocular fundi.
• A potential for permanent reduction in myopia degree was noted.

Conclusions:

• Low-dose atropine sulfate is a safe and effective treatment for slowing myopia progression in children.
• Pharmacological intervention through cycloplegic drug-induced accommodation relaxation may be a viable myopia management strategy.